lets look at CST
96m shares on issue with a market cap of $260 m
as at June 30....had revenues for the FY of $10.5m
and had positive cash flows of $196k in the June quarter.
with $12m in the bank.
Oh yeah...its taking time allright.
funny how CST said in April QFT would receive FDA approval by 30th June
its August.
having delays are we?????
not very transparent in informing shareholders as to why there is a delay.
$260 MILLION market cap
sure some blue sky built into that.
lets look at CST96m shares on issue with a market cap of $260...
Add to My Watchlist
What is My Watchlist?
